
Update, October 15, 2026: Under federal law, marijuana is still a Schedule I controlled substance, with two exceptions: since April 28, 2026, FDA-approved drug products containing marijuana and marijuana covered by a state medical marijuana license are in Schedule III. Recreational (adult-use) marijuana remains illegal under federal law. A separate proposal to move all marijuana to Schedule III is still pending: DEA set a hearing on it to begin June 29, 2026, and no final rule has been published. Official sources: Federal Register final rule 2026-08176 (91 FR 22714) · Federal Register notice of hearing 2026-08177 (91 FR 22777)
Few policy debates capture as much national attention as marijuana rescheduling. For decades, cannabis has been classified as a Schedule I drug, alongside heroin and LSD, officially deemed to have “no medical use.”
But growing medical evidence, state-level legalization, and overwhelming public support have made weed rescheduling one of the most pressing issues in U.S. drug policy.
At the same time, Trump and cannabis policy have emerged as key political talking points. Ever since the 2024 election cycle and 2025 DEA review, questions like “will Trump legalize cannabis?” and “how would Trump handle marijuana rescheduling?” are dominating cannabis news.
This article explores the marijuana rescheduling timeline, DEA and federal updates, Trump on cannabis, and what full federal marijuana legalization would mean for America.
Weed rescheduling refers to moving cannabis from Schedule I to a lower classification (II–V) under the Controlled Substances Act.

Advocates and doctors petitioned the DEA to reschedule marijuana as early as 1972. All efforts were denied for decades.
The DEA reaffirmed cannabis as Schedule I, despite public health data.
In 2023, the Department of Health and Human Services (HHS) recommended moving cannabis to Schedule III.
In 2024, rescheduling news dominated headlines, as the DEA confirmed it was formally reviewing the recommendation.
The DEA marijuana rescheduling decision came in part on April 28, 2026, when FDA-approved products and state-licensed medical marijuana moved to Schedule III. The proposal for all marijuana is still pending. This could be the most significant shift in federal drug law in half a century. But will Trump legalize pot? Doubtful!
It’s essential to distinguish weed rescheduling from federal marijuana legalization.
Trump cannabis policy and future political decisions will determine whether America stops at marijuana rescheduling or moves to full legalization.

Donald Trump has historically taken a mixed stance:
Trump never supported full federal marijuana legalization, but he indicated openness to medical use.
Recently, in campaign discussions, Trump and cannabis legalization has resurfaced, with speculation about whether he would back federal reform if reelected.
Much of the debate around Donald Trump’s cannabis position has relied on his past actions and ambiguous statements.
While he has not issued a detailed plan for federal cannabis reform, Trump has recently signaled skepticism about broad legalization but has remained relatively quiet on the DEA’s current review of the rescheduling recommendation.
So far, his public comments suggest:
Without explicit policy commitments, Trump’s stance remains fluid and influenced by the political climate, his voter base, and congressional action.
While executive agencies like the DEA and HHS hold significant influence, Congress ultimately has the power to reshape federal cannabis law. Current congressional activity includes:
The potential rescheduling of cannabis from Schedule I to Schedule III would have major economic implications for the industry.
Public opinion has shifted dramatically in favor of cannabis reform, making it a central factor in the rescheduling debate.
If federal marijuana legalization occurred, whether under Trump, Biden, or a future administration, the implications would be massive:
Trump cannabis legalization positions and Trump cannabis policy updates will likely influence this timeline, especially if marijuana rescheduling becomes a 2026 election issue.
Partly. Since April 28, 2026, FDA-approved products and state-licensed medical marijuana are Schedule III. All other marijuana is still Schedule I, and a proposal to move all marijuana to Schedule III is still pending.
First petitions in the 1970s, a major denial in 2016, HHS recommendation in 2023, DEA review ongoing in 2024–2025.
No.
FDA-approved products and state-licensed medical marijuana were rescheduled on April 28, 2026. No date has been set for all other marijuana: DEA set a hearing on that proposal to begin June 29, 2026, and no final rule has been published.
Likely rescheduled first. Legalization would require Congress to deschedule cannabis completely.
Trump supports states’ rights and legalized hemp in 2018 but did not pursue marijuana rescheduling during his first term. In 2026, as directed by Executive Order 14370, the Justice Department moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III (effective April 28, 2026); the proposal for all marijuana is still pending.
It’s unclear. Trump could support weed rescheduling as a middle ground but has not committed to full federal marijuana legalization.
The marijuana rescheduling debate is at its most critical point in decades. With the DEA marijuana rescheduling timeline partly completed in April 2026 and both Trump cannabis policy and Biden’s cannabis reforms shaping political momentum, the next year may redefine cannabis in America.
Whether it’s weed rescheduling to Schedule III or eventual federal marijuana legalization, the outcome will impact the economy, justice system, healthcare, and millions of Americans who rely on cannabis for wellness.
As voters weigh Trump and cannabis legalization positions, one thing is clear: the question is no longer if marijuana policy will change , but when.
More in Laws
Check your state's cannabis laws

Compliance, regulations, risk reduction
Copyright Cannabis Training University, a subsidiary of Online Training Providers. © 2026. All Rights Reserved.
Medical Disclaimer: The information on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
Legal Compliance: Cannabis remains federally illegal. Products and information are intended only for jurisdictions where cannabis use and possession is legal.
By using this site, you affirm that you are of legal age (21+) and responsible for understanding your local laws.
